HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walter Futterweit Selected Research

Insulin Resistance

12/2015AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
9/2012Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin.
12/2007Polycystic ovary syndrome: a common reproductive and metabolic disorder necessitating early recognition and treatment.
4/2007Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Walter Futterweit Research Topics

Disease

8Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
12/2015 - 12/2002
4Hyperandrogenism
01/2019 - 12/2005
4Insulin Resistance
12/2015 - 04/2007
2Acne Vulgaris
12/2015 - 11/2015
2Hirsutism
12/2015 - 12/2012
2Anovulation
11/2015 - 12/2012
1Alopecia (Baldness)
01/2019
1Weight Loss (Weight Reduction)
12/2015
1Infertility (Sterility)
12/2015
1Oligomenorrhea
12/2015
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
12/2012
1Inflammation (Inflammations)
12/2012
1Obesity
05/2010
1Type 2 Diabetes Mellitus (MODY)
05/2010
1Cardiovascular Diseases (Cardiovascular Disease)
05/2010
1Gestational Diabetes (Gestational Diabetes Mellitus)
05/2010
1Dyslipidemias (Dyslipidemia)
05/2010
1Kidney Diseases (Kidney Disease)
03/2008
1Hypertension (High Blood Pressure)
03/2008
1Heart Diseases (Heart Disease)
03/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2008
1Diabetes Mellitus
04/2007
1Glucose Intolerance
04/2007
1Genetic Predisposition to Disease (Genetic Predisposition)
12/2002

Drug/Important Bio-Agent (IBA)

9AndrogensIBA
01/2019 - 12/2005
5Insulin (Novolin)FDA Link
12/2015 - 04/2007
3Glucose (Dextrose)FDA LinkGeneric
09/2012 - 04/2007
2LipidsIBA
05/2010 - 03/2008
1Androgen Antagonists (Antiandrogens)IBA
01/2019
1Minoxidil (Rogaine)FDA LinkGeneric
01/2019
1Oral ContraceptivesIBA
12/2015
1Letrozole (Femara)FDA LinkGeneric
12/2015
1Aromatase InhibitorsIBA
12/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2015
1C-Reactive ProteinIBA
12/2015
1Clomiphene (Clomifene)FDA LinkGeneric
12/2015
1LDL CholesterolIBA
12/2015
1Ethinyl Estradiol (Estinyl)FDA LinkGeneric
12/2015
1Testosterone (Sustanon)FDA Link
12/2015
1Isotretinoin (Accutane)FDA LinkGeneric
11/2015
1Biological ProductsIBA
11/2015
1Metformin (Glucophage)FDA LinkGeneric
09/2012
1HDL CholesterolIBA
05/2010
1Spironolactone (Aldactone)FDA LinkGeneric
03/2008
1Alanine Transaminase (SGPT)IBA
03/2008
1Antihypertensive Agents (Antihypertensives)IBA
03/2008
1AlbuminsIBA
03/2008
1HDL LipoproteinsIBA
04/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2002
1Insulin ReceptorIBA
12/2002

Therapy/Procedure

1Therapeutics
12/2015
1Patient Transfer (Patient Dumping)
12/2012
1Aftercare (After-Treatment)
09/2012